# ABACAVIR SULFATE AND LAMIVUDINE
> **ANDA091144** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2017-03-28
## Drug
- **FDA Application Number:** ANDA091144
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABACAVIR SULFATE AND LAMIVUDINE
- **Generic name:** ABACAVIR AND LAMIVUDINE
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2017-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091144)
---
*AI Analytics · CC0 1.0*